Walgreens Boots Alliance (NASDAQ:WBA) : The highest short term price target forecast on Walgreens Boots Alliance (NASDAQ:WBA) is $103 and the lowest target price is $76. A total of 15 equity analysts are currently covering the company. The average price of all the analysts is $93.87 with a standard deviation of $6.49.
Walgreens Boots Alliance, Inc. has dropped 2.1% in the last five trading days, however, the shares have posted positive gains of 6.62% in the last 4 weeks. Walgreens Boots Alliance, Inc. has dropped 3.51% during the last 3-month period . Year-to-Date the stock performance stands at -1.31%. Also, Bank of America reinstates its rating on Walgreens Boots Alliance (NASDAQ:WBA). Analysts at the Bank of America have a current rating of Buy on the shares. The rating by the firm was issued on June 7, 2016.
Walgreens Boots Alliance (NASDAQ:WBA) has an average broker rating of 1.72, which is interpreted as a Buy, as rated by 16 equity analysts. Nonetheless, 9 analysts are positive on the stocks future and they recommend a Strong Buy on the stock. 2 other analysts advise a Buy. Nevertheless, the majority of 5 analysts consider that the stock is a Hold with neither a large upside nor a downside. Ranking by Zacks Investment Research for Coach Inc is 3, which is also a Hold.
Walgreens Boots Alliance (NASDAQ:WBA): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $83.39 and $82.21 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $83.45. The buying momentum continued till the end and the stock did not give up its gains. It closed at $83.27, notching a gain of 0.10% for the day. The total traded volume was 5,813,242 . The stock had closed at $83.19 on the previous day.
In an insider trading activity,The officer (EVP and Global Chief HRO) of Walgreens Boots Alliance, Inc., Wilson-Thompson Kathleen sold 29,603 shares at $83.13 on June 10, 2016. The Insider selling transaction had a total value worth of $2,460,897. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
Walgreens Boots Alliance, Inc. (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led health and wellbeing enterprise. It operates through three segments: Retail Pharmacy USA, which consists of the Walgreens business, including the operation of retail drugstores and convenient care clinics, in addition to providing specialty pharmacy services; Retail Pharmacy International, which consists of the Alliance Boots pharmacy-led health and beauty stores, optical practices and related contract manufacturing operations, and Pharmaceutical Wholesale, which consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. Its portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as global health and beauty product brands, including No7, Botanics, and Soap & Glory. Walgreens Boots Alliance, through its subsidiary, Liz Earle Beauty Co. Ltd, offers the Liz Earle skincare brand.